2025

Hannele Yki-Järvinen: Helsinki University Hospital and Minerva Foundation Institute for Medical research - Finland 
Modulation of glucose-alanine cycling in humans as a novel target to treat type 2 diabetes

Doris Kaltenecker: Institute for Diabetes and Cancer, Helmholtz Munich - Germany 
Spatial characterization into obesity-driven changes of the trigeminal ganglion

José Javier Fuster-Ortuño: National Center for Cardiovascular Research, (CNIC) - Madrid, Spain 
Dissecting the link between clonal haematopoiesis and type 2 diabetes

Maike Sander: Max Delbrück Center for Molecular Medicine - Berlin, Germany 
Enhancing Stem-Cell-Derived Beta Cell Maturation: Integrating Reporters and CRISPR Screens

Inga Prokopenko: University of Surrey - UK 
Precision medicine for personalized Incretin mimetics therapy

Amandine Gautier-Stein: University of Lyon - France 
The vesicular pathway of glucose production is an innovative strategy for preventing and treating type 2 diabetes

2024

Isabella Artner: Lund University - Malmö, Sweden
Characterizing the function of novel islet transcription factors AUTS2 and ETV1 in human pancreatic islet development and function

Federica Benvenuti: International Centre for Genetic Engineering and Biotechnology (ICGEB) - Trieste, Italy
Does hyperglycaemia suppress tumor immune surveillance by dendritic cells?

Brice Emanuelli: University of Copenhagen - Denmark
Elucidation of a novel ketone-fatty acid cycling in the function of brown adipose tissue

Maria Lindahl: University of Helsinki - Finland
Novel METTL3/14 methyltransferase activators for protecting pancreatic beta cells in diabetes mellitus

Nadav Sharon: Technion, Israel Institute of Technology - Haifa, Israel
Uncovering the Heterogeneous Potential of Pancreatic Beta Cell Proliferation

2023

Alastair Kerr: Karolinska Institute - Huddinge, Sweden
A missing link (RNA) in fat breakdown regulation

Fredrik Bäckhed: University of Gothenburg - Sweden
Gut microbial regulation of colonic GLP-1 production and effects on gut physiology

Jurga Laurencikiene: Karolinska Institute - Huddinge, Sweden
Type 2 diabetes and adipose tissue morphology: dual role and sex-specificity of the immune component

Luis Rodrigo Cataldo: Lund University - Malmö, Sweden
EPDR1 – a novel human batokine regulating beta cell function and glucose homeostasis

Zachary Gerhart-Hines: University of Copenhagen - Denmark
Nocturnal thermogenesis as a driver of metabolic health and defense against weight gain in humans

2022

Sonia Fernandez Veledo: Pere Virgili Health Research Institute - Tarragona, Spain
NEUROinflammatory role of the succinate/SUCNR1 axis in obesity-related DIAbetes (NEURO_DIA)

Filip Knop: University of Copenhagen - Denmark
Separate and combined extrapancreatic effects of the incretin hormones

Vito Lampasona: Vita-Salute San Raffaele University - Milan, Italy
Insulin granules proteins: novel autoimmune targets and biomarkers in type 1 diabetes

Gil Leibowitz: Hadassah-Hebrew University Medical Center - Jerusalem, Israel
Fructose is central in diabetic kidney disease and mediates the protective effects of SGLT2 inhibitors

Peter van Endert: INSERM U1151 - Paris, France
Tolerogenic nanoparticles inducing regulatory B and T lymphocytes for therapy of autoimmune diabetes

2021

Elise Dalmas: INSERM U1138 - Paris, France
CD200: a novel immune rheostat of pancreatic islets

Franck Oury: INSERM U1151 - Paris, France
Investigation of a PTHrp/autophagy axis in the control of metabolism and as a new therapeutic target

Kirsty Spalding: Karolinska Institutet - Stockholm, Sweden
Cell regeneration in the human kidney in health and diabetic kidney disease

Nicolas Venteclef: INSERM U1138 - Paris, France
Impact of KMD6B dependent-epigenetic reprogramming of adipose tissue macrophage plasticity in type 2 diabetes

Harriet Wallberg-Henriksson: Karolinska Institutet - Stockholm, Sweden
Exercise response and circadian rhythm for type 2 diabetes prevention and management

Juleen Zierath: Karolinska Institutet - Stockholm, Sweden
Role of energy sensing pathways in the circadian control of metabolism

2020

Charna Dibner: University of Geneva - Switzerland
Bridging the gap between disrupted circadian clocks and human islet function upon type 2 diabetes

Mario Galgani: Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G.Salvatore" - Naples, Italy
TR3-56 cells: the missing piece in the puzzle of type 1 diabetes progression

Mariana Igoillo-Esteve: Université Libre de Bruxelles - Belgium
tRNA hypomethylation and fragmentation, a novel mechanism of pancreatic beta cell demise in diabetes

Susanne Keipert: Stockholm University - Sweden
The impact of FGF21 sensitivity on metabolic syndrome progression

Anja Zeigerer: Helmholtz Center Munich - Neuherberg, Germany
Identification of the novel role of Vps33b in blood glucose control